初創企業·2026年5月29日·來源： Pr Newswire Apac
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
內容只提供英文版本
BOSTON , May 29, 2026 /PRNewswire/ -- XtalPi (2228. HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical company DoveTree Medicines Unus Inc.
#xtalpi#dovetree medicines unus inc.#ind-enabling studies#advances#dynamic conformation precision modeling platform#strategic collaboration#receives#surerxn reaction prediction model
原文報道： Pr Newswire Apac我們不轉載全文， 閱讀原文 →
